Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2010
06/01/2010US7728128 Dibenzo[c,h][1,5]naphthyridines and their use as DNA probes
06/01/2010US7727727 Pretreatment method for extraction of nucleic acid from biological samples and kits therefor
06/01/2010US7727713 Templated molecules and methods for using such molecules
06/01/2010CA2448737C Viral polymerase inhibitors
05/2010
05/27/2010US20100130735 Antiviral nucleosides
05/27/2010US20100130734 Process for preparing capecitabine
05/27/2010US20100130733 Luminescent metal ion complexes
05/27/2010US20100130440 Antiviral nucleosides
05/27/2010US20100130438 Method for increasing oxytocin release in the epidermis
05/27/2010US20100129317 Azole nucleosides and use as inhibitors of rna and dna viral polymerases
05/26/2010EP2189467A2 Method of fluorination by microwaves
05/26/2010EP2189466A2 Method of fluorination by microwaves
05/26/2010EP2188298A2 Tetrahydropyran nucleic acid analogs
05/26/2010EP2014671B1 Methods and compositions for identifying and characterizing hepatitis C
05/26/2010CN1659179B System for tracing animal products
05/26/2010CN101712709A Tifluoroacetyl-3-hydroxyphenyl adenosine and use thereof in blood fat regulation
05/26/2010CN101712708A Method for preparing decitabine
05/25/2010US7723512 Oligonucleotides comprising a non-phosphate backbone linkage
05/25/2010US7723495 Amidite for nucleic acid synthesis and nucleic acid synthesizing method
05/25/2010US7723319 1-[(6-amino-9H-purin-9-yl)methyl]cyclopropyl}oxy)methylphosphonic acid; hepatitis virus
05/25/2010US7723038 Amplification methods
05/25/2010US7722886 Therapeutic agent comprising cytokine inhibitory activity for use in treatment of respiratory system disorders; viricides; antisense agents; enzyme inhibitors; immunotherapy; RNA interference; recombinant cytokine receptors
05/25/2010CA2464681C Preparation of thioarabinofuranosyl compounds and use thereof
05/20/2010WO2010057185A1 Phospholink nucleotides for sequencing applications
05/20/2010WO2010036407A3 Antiviral nucleoside analogs
05/20/2010WO2008121634A3 Nucleoside phosphoramidate prodrugs
05/19/2010EP2186801A2 Intermediates for synthesizing dibenzorhodamine dyes
05/19/2010CN1982323B A preparing process of 1-(2'-deoxy-2',2'-difluoro-D-ribofuranosyl)-4-aminopyrimidin-2-on or thereof hydrochloric salt
05/19/2010CN101711263A Continuous counter-current organosolv processing of lignocellulosic feedstocks
05/19/2010CN101709073A Nucleotide phospholipid molecule and lipidosome and preparation method and application thereof
05/19/2010CN101066987B Preparation process of brivudine
05/18/2010US7718790 1st and 2nd primer sets provide a first detectable signal on the occurrence of amplification of mitochondrial nucleic acid and second signal on the occurrence of amplification of host nuclear nucleic acid; probe comprising a 6-carboxyfluorescein reporter, 5-carboxytetramethylrhodamine quencher molecule
05/18/2010US7718789 Compositions and methods for the modification of gene expression
05/18/2010US7718374 Probes for continuous monitoring of replication; solid phase synthesis; distinguishing in a sample between wild-type, mutant and heterozygous target polynucleotides
05/18/2010US7718364 for assessing allelic losses and hypermethylation of genes in CpG tumor promotor region on specific chromosomal regions in cancer patients, including melanoma, neuroblastoma breast, colorectal, and prostate cancer patients
05/18/2010CA2318581C Force discrimination assay
05/14/2010WO2010054032A2 Apparatus and method using rotary flow distribution mechanisms
05/14/2010CA2742744A1 Apparatus and method using rotary flow distribution mechanisms
05/13/2010US20100121045 Bis-modified bicyclic nucleic acid analogs
05/13/2010US20100120709 Cytidine derivative-containing antitumor agent for continuous intravenous administration
05/12/2010CN1795200B Process for producing 2 -deoxy-2 -fluorouridine
05/12/2010CN1715918B Configurable dynamic three dimensional array
05/12/2010CN101704850A Method for separating and extracting compound of Amadori of Maillard reaction midbody
05/11/2010US7715989 Systems and methods for predicting oligonucleotide melting temperature (TmS)
05/11/2010US7714123 Crystalline forms of an antiviral benzimidazole compound
05/11/2010US7713941 Tricyclic nucleosides or nucleotides as therapeutic agents
05/11/2010US7713698 Determining sequence of preferential DNA sequences
05/11/2010CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/06/2010WO2010049611A1 Polysaccharide- and polypeptide-based block copolymers, vesicles constituted of these copolymers and use thereof
05/06/2010WO2009139719A9 Novel synthesis of galactoside inhibitors
05/06/2010US20100113763 Method for preparation of organofluoro compounds in alcohol solvents
05/06/2010US20100113762 Apparatus and Method Using Rotary Flow Distribution Mechanisms
05/06/2010US20100113759 Propargyl substituted nucleoside compounds and methods
05/06/2010US20100113381 Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
05/06/2010US20100112561 Fluorescent nucleoside analogues
05/06/2010CA2741246A1 Polysaccharide- and polypeptide-based block copolymers, vesicles constituted of these copolymers and use thereof
05/05/2010EP2181988A1 Pharmaceutical Compositions based on Crystalline Form I of 5-Azacytidine
05/05/2010EP1546354B1 Analyte detection
05/05/2010EP0832299B1 Use of nucleic acid ligands in flow cytometry
05/05/2010CN1910194B Synthesis of spongosine
05/05/2010CN1594342B Glycosyl phthalic imidine compounds with anti-inflammatory activity
05/04/2010US7709459 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
05/04/2010CA2433840C Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
05/04/2010CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression
04/2010
04/29/2010WO2010011312A9 Universal methylation profiling methods
04/29/2010WO2010005799A3 Novel acetates of 2-deoxy monosaccharides with anticancer activity
04/29/2010US20100105888 Separation process
04/29/2010US20100105887 Process for the preparation of gemcitabine hydrochloride
04/29/2010US20100105880 Purification of carbon nanotubes via biomolecules
04/29/2010US20100105030 Nucleic acid base pairs
04/29/2010US20100104532 Nucleoside analogs for antiviral treatment
04/29/2010DE102008053284A1 Stabilizer, useful for stabilizing heparin-binding growth factors and for manufacturing medicament e.g. for wound healing and bone regeneration, comprises a compound having an oligophosphate group
04/29/2010CA2741294A1 5' and 2' bis-substituted nucleosides and oligomeric compounds prepared therefrom
04/28/2010EP2180064A2 Multiplex quantification of nucleic acids in diseased cells
04/28/2010EP2180005A1 Process for the preparation of gemcitabine chlorohydrate
04/28/2010EP2179996A1 Sulfonated diarylrhodamine dyes
04/28/2010CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine,
04/28/2010CN101698820A Method for producing white wine and fruit wine by fritillary bulb
04/27/2010US7704971 Uracil reductase inactivators
04/27/2010US7704961 Miticides and nematocides well-tolerated by livestock and domestic animals; effective against pesticide-resistant pests; protection for plant propagation material
04/27/2010CA2449180C Viral polymerase inhibitors
04/22/2010WO2008142055A3 Antiviral agents
04/22/2010US20100099643 Fused Pentacyclic Polyethers
04/21/2010EP2177627A1 Manipulation of microparticles in microfluidic systems
04/21/2010EP2177527A1 2'-fluoro-4'-substituted nucleosides, the preparation and use
04/21/2010EP2176280A2 6-disubstituted bicyclic nucleic acid analogs
04/21/2010EP2176279A2 Stable highly pure azacitidine and preparation methods therefor
04/21/2010EP2176278A2 2',3'-di-o-acyl-5-fluoronucleosides
04/21/2010EP2176277A2 Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof
04/21/2010CN101696228A N-pyrazolyl glycosides derivatives as well as preparation method and application thereof
04/20/2010US7700770 recrystallizing from a polar aprotic solvent (dimethylsulfoxide, dimethylformamide, dimethylacetamide, or N-methylpyrrolidinone) and a cosolvent (acetonitrile, ethanol, methylethyl ketone, isopropyl alcohol, or 1-propanol); myelodysplastic syndrome
04/20/2010US7700763 3-triazolyl-galactoside inhibitors of galectins
04/20/2010US7700761 3-deoxypentopyranosyl nucleic acid, its production and its use
04/20/2010CA2410579C Methods and compositions for treating flaviviruses and pestiviruses
04/15/2010WO2010040286A1 Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat
04/15/2010WO2009143369A3 Method of preparing nucleosides and analogs thereof without using chromatography
04/15/2010US20100094003 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
04/15/2010US20100093992 Macromolecular Nucleotide Compounds and Methods for Using the Same
04/15/2010US20100093991 Methods for the preparation of 9-deazapurine derivatives
04/15/2010US20100093990 Nucleotide with an Alpha-Phosphate Mimetic
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 201